Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

The ACR Agenda in D.C.: Where We Stand in Mid-April

Angus B. Worthing, MD, FACP, FACR  |  

Angus’s To-Do List
Keep Rheumatology Strong and join the AMA. You can win free hotel or registration for ACR San Diego! We still need roughly 200 more ACR members to join the AMA this year in order to keep our AMA delegate and leverage our initiatives with the house of medicine. Call 800-621-8335 or sign up online, and forward this bulletin to your ACR friends.

  • Download the Voter Voice app on your Android or iPhone. It offers a quick way to write letters to your members of Congress about ACR initiatives.
  • Go here to tell your Member of Congress to create a rheumatology research fund at the DoD. It takes less than a minute!
  • Invest in RheumPAC.

Angus B. Worthing, MD, FACP, FACR, is a practicing rheumatologist at Arthritis & Rheumatism Associates PC in Washington, D.C., and the chair of the ACR’s Government Affairs Committee.

ADVERTISEMENT
SCROLL TO CONTINUE

Related Articles

    Trump Appears to Be Losing Battle Ahead of Healthcare Vote

    WASHINGTON (Reuters)—U.S. President Donald Trump and Republican congressional leaders appeared on Wednesday to be losing the battle to get enough support in the House of Representatives to pass their Obamacare rollback bill, watched by wary investors in financial markets. The current House Republican rollback plan is scheduled for a floor vote on Thursday but faces…

    U.S. House Vote Looms; Trump Struggles to Win Obamacare Repeal


    WASHINGTON (Reuters)—U.S. President Donald Trump made a final push on Thursday to win over skeptical members of his own Republican Party to begin dismantling Obamacare in the House of Representatives or risk failure on one of his top legislative priorities. The effort is seen by financial markets as a crucial test of Trump’s ability to…

    White House Preparing Order that Would Cut Drug Prices for Medicare

    (Reuters)—U.S. President Donald Trump is considering a sweeping executive order that would cut prices on virtually all branded prescription drugs sold to Medicare and other government programs, according to two industry sources who had discussions with the White House. The order under discussion would be much broader than the Administration’s previously disclosed proposal to lower…

    U.S. States Plan Suit to Block Trump Obamacare Subsidies Cut

    WASHINGTON/SAN FRANCISCO (Reuters)—On Friday, California, New York and others states vowed to sue President Donald Trump’s administration to stop him from scrapping a key component of Obamacare, subsidies to insurers that help millions of low-income people pay medical expenses, even as Trump invited Democratic leaders to negotiate a deal. One day after his administration announced…